Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Free Cash Flow (2018 - 2025)

BioNexus Gene Lab's Free Cash Flow history spans 8 years, with the latest figure at $960085.0 for Q4 2025.

  • Quarterly results put Free Cash Flow at $960085.0 for Q4 2025, up 346.18% from a year ago — trailing twelve months through Dec 2025 was -$1.9 million (up 19.17% YoY), and the annual figure for FY2025 was -$1.9 million, up 19.17%.
  • Free Cash Flow for Q4 2025 was $960085.0 at BioNexus Gene Lab, up from -$1.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $960085.0 in Q4 2025 to a low of -$1.8 million in Q3 2024.
  • The 5-year median for Free Cash Flow is -$93325.0 (2022), against an average of -$283178.1.
  • Peak annual rise in Free Cash Flow hit 346.18% in 2025, while the deepest fall reached 1309.73% in 2025.
  • Year by year, Free Cash Flow stood at $481728.0 in 2021, then dropped by 4.57% to $459712.0 in 2022, then crashed by 270.42% to -$783463.0 in 2023, then surged by 127.47% to $215181.0 in 2024, then soared by 346.18% to $960085.0 in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $960085.0, -$1.2 million, and -$759366.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.